These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25265310)

  • 21. Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up.
    Gibbie T; Mijch A; Ellen S; Hoy J; Hutchison C; Wright E; Chua P; Judd F
    HIV Med; 2006 Mar; 7(2):112-21. PubMed ID: 16420256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Working memory deficits in HIV-seropositive drug users.
    Bartok JA; Martin EM; Pitrak DL; Novak RM; Pursell KJ; Mullane KM; Harrow M
    J Int Neuropsychol Soc; 1997 Sep; 3(5):451-6. PubMed ID: 9322404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between age and cognitive function in HIV-infected men.
    Kissel EC; Pukay-Martin ND; Bornstein RA
    J Neuropsychiatry Clin Neurosci; 2005; 17(2):180-4. PubMed ID: 15939971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings.
    Cherner M; Ellis RJ; Lazzaretto D; Young C; Mindt MR; Atkinson JH; Grant I; Heaton RK;
    AIDS; 2004 Jan; 18 Suppl 1():S27-34. PubMed ID: 15075495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subjective complaints versus actual cognitive deficits in predominantly symptomatic HIV-1 seropositive individuals.
    Moore LH; van Gorp WG; Hinkin CH; Stern MJ; Swales T; Satz P
    J Neuropsychiatry Clin Neurosci; 1997; 9(1):37-44. PubMed ID: 9017527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV infection and cognition in intravenous drug users: long-term follow-up.
    Selnes OA; Galai N; McArthur JC; Cohn S; Royal W; Esposito D; Vlahov D
    Neurology; 1997 Jan; 48(1):223-30. PubMed ID: 9008522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive risk factors and neuropsychological performance in HIV infection.
    Claypoole KH; Townes BD; Collier AC; Marra C; Longstreth WT; Cohen W; Martin D; Coombs RW; Goldstein D; Sanchez P
    Int J Neurosci; 1993 May; 70(1-2):13-27. PubMed ID: 8083020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neurocognitive impairment related to acquired immunodeficiency syndrome in socially-excluded former intravenous drug abusers].
    Vergara-Moragues E; de Campos AV; Girón-González JA
    Enferm Infecc Microbiol Clin; 2010 May; 28(5):294-6. PubMed ID: 19716207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A screening algorithm for HIV-associated neurocognitive disorders.
    Cysique LA; Murray JM; Dunbar M; Jeyakumar V; Brew BJ
    HIV Med; 2010 Nov; 11(10):642-9. PubMed ID: 20456505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropsychological impairment and the natural history of HIV-1 infection in Spanish subjects.
    Rodríguez Alvarez M; Faílde Garrido JM; Simón López MA
    Funct Neurol; 2007; 22(3):165-70. PubMed ID: 17925167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Employment on Neurocognitive Reserve in Adults With HIV: A Review of the Literature.
    Vance DE; Cody SL; Yoo-Jeong M; Jones GL; Nicholson WC
    J Assoc Nurses AIDS Care; 2015; 26(4):316-29. PubMed ID: 26066688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of chronic substance abuse on the neuropsychological performance of intravenous drug users with a high prevalence of HIV-1 seropositivity.
    Concha M; Graham NM; Muñoz A; Vlahov D; Royal W; Updike M; Nance-Sproson T; Selnes OA; McArthur JC
    Am J Epidemiol; 1992 Dec; 136(11):1338-48. PubMed ID: 1362630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of cognitive reserve on neuropsychological functioning following coronary artery bypass grafting (CABG).
    Ropacki SA; Bert AA; Ropacki MT; Rogers BL; Stern RA
    Arch Clin Neuropsychol; 2007 Jan; 22(1):73-85. PubMed ID: 17161581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between self-report of cognitive impairment, HIV status, and cocaine use in a sample of cocaine-dependent methadone-maintained patients.
    Avants SK; Margolin A; McMahon TJ; Kosten TR
    Addict Behav; 1997; 22(5):599-611. PubMed ID: 9347062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between age and cognitive impairment in HIV-1 infection: findings from the Multicenter AIDS Cohort Study and a clinical cohort.
    van Gorp WG; Miller EN; Marcotte TD; Dixon W; Paz D; Selnes O; Wesch J; Becker JT; Hinkin CH; Mitrushina M
    Neurology; 1994 May; 44(5):929-35. PubMed ID: 8190299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive reserve as a protective factor in older HIV-positive patients at risk for cognitive decline.
    Foley JM; Ettenhofer ML; Kim MS; Behdin N; Castellon SA; Hinkin CH
    Appl Neuropsychol Adult; 2012; 19(1):16-25. PubMed ID: 22385375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study.
    Schilt T; de Win MM; Koeter M; Jager G; Korf DJ; van den Brink W; Schmand B
    Arch Gen Psychiatry; 2007 Jun; 64(6):728-36. PubMed ID: 17548754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychological impairment among intravenous drug users in pre-AIDS stages of HIV infection.
    Wellman MC
    Int J Neurosci; 1992; 64(1-4):183-94. PubMed ID: 1342038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive reserve and neuropsychological functioning in older HIV-infected people.
    Milanini B; Ciccarelli N; Fabbiani M; Limiti S; Grima P; Rossetti B; Visconti E; Tamburrini E; Cauda R; Di Giambenedetto S
    J Neurovirol; 2016 Oct; 22(5):575-583. PubMed ID: 26965299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia.
    Ciccarelli N; Fabbiani M; Colafigli M; Trecarichi EM; Silveri MC; Cauda R; Murri R; De Luca A; Di Giambenedetto S
    Antivir Ther; 2013; 18(2):153-60. PubMed ID: 23486721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.